1. [1] Syed V, Ulinski G, Mok SC, et al. Expression of gonadotrophin receptors and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res 2001;61(18):6768 -76.
2. Risk factors and risk reduction of breast and ovarian cancer;Brekelmans;Curr Opin Obstet Gynecol,2003
3. Hormonal replacement therapy and endometrial, ovarian and colorectal cancer;Gambacciani;Best Pract Res Clin Endocrinol Metab,2003
4. [4] Qureshi A, Pervez S. Allred score for ER reporting and its impact in clearly distinguishing ER negative from ER positive breast cancers. J Pak Med Assoc 2010;60(5):350-3.
5. [5] Garg S, Marwah N, Chauhan G, et al. Estrogen and progesterone receptor expression and its correlation with various clinicopathological parameters in ovarian tumours. Middle East Journal of Cancer 2014;5(2):97-103.